Keynote Session - Quantitative clinical pharmacology/pharmacometrics facilitate decision making in drug development

Keynote Speaker(s)

• PS

  Peter Stein, MD

  Director, Office of New Drugs
  The U.S. Food and Drug Administration

  Disclosure(s): No financial relationships to disclose